AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 135 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $30,980 | -26.2% | 13,296 | +93.3% | 0.00% | – |
| Q1 2021 | $42,000 | -41.7% | 6,878 | -54.9% | 0.00% | – |
| Q4 2020 | $72,000 | +278.9% | 15,260 | +233.0% | 0.00% | – |
| Q3 2020 | $19,000 | -70.3% | 4,582 | -68.4% | 0.00% | – |
| Q2 2020 | $64,000 | +433.3% | 14,490 | +271.3% | 0.00% | – |
| Q1 2020 | $12,000 | -83.3% | 3,902 | -73.8% | 0.00% | – |
| Q4 2019 | $72,000 | +200.0% | 14,913 | +81.5% | 0.00% | – |
| Q3 2019 | $24,000 | -60.0% | 8,216 | -3.1% | 0.00% | – |
| Q2 2019 | $60,000 | -6.2% | 8,475 | +87.5% | 0.00% | – |
| Q1 2019 | $64,000 | -85.6% | 4,521 | -86.2% | 0.00% | – |
| Q4 2018 | $444,000 | -37.7% | 32,755 | +2.0% | 0.00% | -100.0% |
| Q3 2018 | $713,000 | +31.8% | 32,128 | -2.6% | 0.00% | – |
| Q2 2018 | $541,000 | – | 32,969 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |